Detalles de la búsqueda
1.
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors.
Int J Clin Oncol
; 27(12): 1881-1890, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36344654
2.
Longitudinal study of breast cancer risk markers.
Breast J
; 27(1): 48-51, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33099843
3.
Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease.
J Natl Compr Canc Netw
; : 1-10, 2020 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33142266
4.
Effects of vitamin D supplementation on a deep learning-based mammographic evaluation in SWOG S0812.
JNCI Cancer Spectr
; 2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38814817
5.
Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update.
J Clin Oncol
; 39(18): 2037-2048, 2021 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33939491
6.
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series.
Cardiooncology
; 5: 1, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32154008
7.
Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812).
Cancer Prev Res (Phila)
; 12(7): 481-490, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31138522
8.
Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer.
JAMA Oncol
; 5(8): 1132-1140, 2019 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31194225
9.
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial.
J Immunother Cancer
; 6(1): 111, 2018 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30348224
10.
Early-Onset 5-Fluorouracil Toxicity in a Patient Negative for Dihydropyrimidine Dehydrogenase Mutations: The Clinical Course of Reversal with Uridine Triacetate.
Pharmacotherapy
; 36(11): e178-e182, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27716991
11.
Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer.
Cancer Res
; 73(8): 2457-2467, 2013 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23423981
12.
Induction of antitumor immunity ex vivo using dendritic cells transduced with fowl pox vector expressing MUC1, CEA, and a triad of costimulatory molecules (rF-PANVAC).
J Immunother
; 35(7): 555-69, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22892452
13.
Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28.
J Immunother
; 33(2): 155-66, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20145548
14.
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer.
J Clin Oncol
; 27(33): 5601-6, 2009 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19826113
15.
Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.
J Immunol
; 181(1): 808-21, 2008 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18566447
Resultados
1 -
15
de 15
1
Próxima >
>>